- Home
- AOMR vs VXRT Comparison
AOMR vs VXRT Comparison
Compare AOMR & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOMR
- VXRT
- Stock Information
- Founded
- AOMR 2018
- VXRT N/A
- Country
- AOMR United States
- VXRT United States
- Employees
- AOMR N/A
- VXRT N/A
- Industry
- AOMR Real Estate Investment Trusts
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AOMR Real Estate
- VXRT Health Care
- Exchange
- AOMR Nasdaq
- VXRT Nasdaq
- Market Cap
- AOMR 240.9M
- VXRT 200.3M
- IPO Year
- AOMR 2021
- VXRT N/A
- Fundamental
- Price
- AOMR $9.81
- VXRT $0.58
- Analyst Decision
- AOMR Buy
- VXRT Strong Buy
- Analyst Count
- AOMR 6
- VXRT 2
- Target Price
- AOMR $12.10
- VXRT $3.00
- AVG Volume (30 Days)
- AOMR 119.1K
- VXRT 1.5M
- Earning Date
- AOMR 11-06-2024
- VXRT 11-13-2024
- Dividend Yield
- AOMR 13.06%
- VXRT N/A
- EPS Growth
- AOMR N/A
- VXRT N/A
- EPS
- AOMR 2.91
- VXRT N/A
- Revenue
- AOMR $94,441,000.00
- VXRT $16,760,000.00
- Revenue This Year
- AOMR N/A
- VXRT $67.95
- Revenue Next Year
- AOMR $29.25
- VXRT N/A
- P/E Ratio
- AOMR $3.37
- VXRT N/A
- Revenue Growth
- AOMR 455.18
- VXRT 303.27
- 52 Week Low
- AOMR $8.88
- VXRT $0.52
- 52 Week High
- AOMR $13.32
- VXRT $1.54
- Technical
- Relative Strength Index (RSI)
- AOMR 52.63
- VXRT 24.96
- Support Level
- AOMR $9.80
- VXRT $0.67
- Resistance Level
- AOMR $10.11
- VXRT $0.75
- Average True Range (ATR)
- AOMR 0.22
- VXRT 0.05
- MACD
- AOMR 0.11
- VXRT -0.01
- Stochastic Oscillator
- AOMR 75.20
- VXRT 0.04
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rates and credit cycles.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.